Cargando…
AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis
The RAS–BRAF signaling is a major pathway of cell proliferation and their mutations are frequently found in human cancers. Adenylate kinase 2 (AK2), which modulates balance of adenine nucleotide pool, has been implicated in cell death and cell proliferation independently of its enzyme activity. Rece...
Autores principales: | Kim, Hyunjoo, Jeong, Muhah, Na, Do-Hyeong, Ryu, Shin-Hyeon, Jeong, Eun Il, Jung, Kwangmin, Kang, Jaemin, Lee, Ho-June, Sim, Taebo, Yu, Dae-Yeul, Yu, Hee Chul, Cho, Baik-Hwan, Jung, Yong-Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117275/ https://www.ncbi.nlm.nih.gov/pubmed/35585049 http://dx.doi.org/10.1038/s41419-022-04921-7 |
Ejemplares similares
-
Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3
por: Lee, Song-Yi, et al.
Publicado: (2019) -
Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance
por: Kim, Namkyoung, et al.
Publicado: (2021) -
Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014) -
ak 47 /
por: Aguilar Martínez, Luis
Publicado: (2017) -
Copper is required for oncogenic BRAF signaling and tumorigenesis
por: Brady, Donita C., et al.
Publicado: (2014)